Lindsay Rocco | Elixir Health Public Relations |
John Johnson | Executive Chairman |
Scott Wilhoit | CCO |
Fred Cohen | Chief Medical Officer |
Robert Lutz | CFO |
Annabel Samimy | Stifel |
Roger Song | Jefferies |
Justin Kim | Oppenheimer & Company |
Jon Wolleben | Securities |
Good afternoon ladies and gentlemen, and welcome to the Strongbridge Biopharma plc Corporate Update and Third Quarter 2019 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.
I would now like to turn the conference over to your host, Ms. Lindsay Rocco of Elixir Health Public Relations. Ma'am, please go ahead.